These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19250755)

  • 1. Evo-Devo and the evolution of cancer: a hypothesis for metamorphic therapies for the cancers of prolactin-influenced tumourigenesis: with special reference to glioblastoma multiforme (GBM).
    Pearson RD
    Med Hypotheses; 2009 Jun; 72(6):629-30. PubMed ID: 19250755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin.
    Katsetos CD; Dráberová E; Legido A; Dumontet C; Dráber P
    J Cell Physiol; 2009 Dec; 221(3):505-13. PubMed ID: 19650075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer therapies for glioblastoma multiforme.
    Sathornsumetee S; Rich JN
    Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?
    Goffin V; Touraine P; Culler MD; Kelly PA
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):571-81. PubMed ID: 17024156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGFRvIII variant in glioblastoma multiforme.
    Gan HK; Kaye AH; Luwor RB
    J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin.
    Katsetos CD; Dráberová E; Legido A; Dráber P
    J Cell Physiol; 2009 Dec; 221(3):514-20. PubMed ID: 19650077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the study of brain tumor stem cells as treatment targets].
    Hide T; Kuratsu J
    Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence cancer stem cells--made by cell fusion?
    Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
    Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution.
    Piccirillo SG; Combi R; Cajola L; Patrizi A; Redaelli S; Bentivegna A; Baronchelli S; Maira G; Pollo B; Mangiola A; DiMeco F; Dalprà L; Vescovi AL
    Oncogene; 2009 Apr; 28(15):1807-11. PubMed ID: 19287454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensing invasion: cell surface receptors driving spreading of glioblastoma.
    Teodorczyk M; Martin-Villalba A
    J Cell Physiol; 2010 Jan; 222(1):1-10. PubMed ID: 19688773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
    Li Y; Li W; Yang Y; Lu Y; He C; Hu G; Liu H; Chen J; He J; Yu H
    Brain Res; 2009 Aug; 1286():13-8. PubMed ID: 19559015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer stem cells--insights and perspectives.
    Hermann PC; Mueller MT; Heeschen C
    Expert Opin Biol Ther; 2009 Oct; 9(10):1271-8. PubMed ID: 19723015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oxygen in regulating neural stem cells in development and disease.
    Panchision DM
    J Cell Physiol; 2009 Sep; 220(3):562-8. PubMed ID: 19441077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodothyronine deiodinases and thyroid hormone receptors regulation during flatfish (Solea senegalensis) metamorphosis.
    Isorna E; Obregon MJ; Calvo RM; Vázquez R; Pendón C; Falcón J; Muñoz-Cueto JA
    J Exp Zool B Mol Dev Evol; 2009 May; 312B(3):231-46. PubMed ID: 19306324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay.
    Glantz M; Kesari S; Recht L; Fleischhack G; Van Horn A
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S17-24. PubMed ID: 19660679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin.
    Trott JF; Horigan KC; Gloviczki JM; Costa KM; Freking BA; Farmer C; Hayashi K; Spencer T; Morabito JE; Hovey RC
    J Endocrinol; 2009 Jul; 202(1):153-66. PubMed ID: 19401343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.